{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:54:40Z","timestamp":1791262480933,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110505","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:58:29Z","timestamp":1789052309000},"page":"110505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of new 1-aryl-3-phenylureas as promising PDGFRa and VEGFR-2 inhibitors and apoptosis inducers"],"prefix":"10.1016","volume":"182","author":[{"given":"Magda M.F.","family":"Ismail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma A.","family":"Abdelkhalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona H.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110505_bb0005","doi-asserted-by":"crossref","unstructured":"H Sung, J Ferlay, R L Siegel, M Laversanne, I Soerjomataram, A Jemal, F Bray. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin. 71 (2021) 209\u2013249. Doi: https:\/\/doi.org\/10.3322\/caac.21660.","DOI":"10.3322\/caac.21660"},{"key":"10.1016\/j.bioorg.2026.110505_bb0010","article-title":"A review of global cancer prevalence and therapy","volume":"1","author":"Obafemi","year":"2023","journal-title":"J. Cancer Res. Treat & Prev."},{"key":"10.1016\/j.bioorg.2026.110505_bb0015","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2026.110505_bb0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fchem.2017.00089","article-title":"Platelet-rich plasma derived growth factors contribute to stem cell differentiation in musculoskeletal regeneration","volume":"5","author":"Qian","year":"2017","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2026.110505_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13010006","article-title":"Vascular Endothelial Growth Factor (VEGF) family and the immune system: activators or inhibitors?","volume":"13","author":"Failla","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2026.110505_bb0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3390\/biom11020253","article-title":"Role of Vascular Endothelial Growth Factor (VEGF) in human embryo implantation: clinical implications","volume":"11","author":"Guo","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2026.110505_bb0035","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s12272-025-01545-1","article-title":"Targeting vascular endothelial growth receptor-2 (VEGFR-2): structural biology, functional insights, and therapeutic resistance","volume":"48","author":"Shah","year":"2025","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bioorg.2026.110505_bb0040","article-title":"An overview of agents and treatments for PDGFRA-mutated gastrointestinal stromal tumors","volume":"12","author":"Sun","year":"2022","journal-title":"Front. Oncol."},{"issue":"45","key":"10.1016\/j.bioorg.2026.110505_bb0045","doi-asserted-by":"crossref","first-page":"33384","DOI":"10.1039\/D4RA05244G","article-title":"A Arun Shirkhedkar, Recent updates on potential of VEGFR-2 small-molecule inhibitors as anticancer agents","volume":"14","author":"Chaudhari","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110505_bb0050","first-page":"854","article-title":"MAPK\/ERK Signaling in tumorigenesis: mechanisms of growth, invasion, and angiogenesis","volume":"24","author":"Fei","year":"2025","journal-title":"EXCLI J."},{"key":"10.1016\/j.bioorg.2026.110505_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109617","article-title":"Expanding landscape of kinase inhibitor research in 25 years (2001-2025) and advancements of next-generation kinase inhibitors","volume":"173","author":"Das","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110505_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129971","article-title":"Discovery of novel, orally bioavailable phenylacetamide derivatives as multikinase inhibitors and in vivo efficacy study in hepatocellular carcinoma animal models","volume":"113","author":"Das","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110505_bb0065","doi-asserted-by":"crossref","unstructured":"R. Roskoski Jr., Properties of FDA-approved small molecule protein kinase inhibitors: A 2026 update, Pharmacol. Res., 224, (2026),108107, Doi: https:\/\/doi.org\/10.1016\/j.phrs.2026.108107.","DOI":"10.1016\/j.phrs.2026.108107"},{"issue":"10","key":"10.1016\/j.bioorg.2026.110505_bb0070","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.3390\/ijms25105489","article-title":"Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future Perspectives","volume":"25","author":"Li","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110505_bb0075","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2278022","article-title":"Novel N-Arylmethyl-aniline\/chalcone hybrids as potential VEGFR inhibitors: synthesis, biological evaluations, and molecular dynamic simulations","volume":"38","author":"Haffez","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110505_bb0080","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.3390\/molecules27196203","article-title":"Discovery of new VEGFR-2 inhibitors: design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies","volume":"27","author":"Elkaeed","year":"2022","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.bioorg.2026.110505_bb0085","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1016\/j.ejmech.2010.09.002","article-title":"Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors","volume":"45","author":"Lee","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110505_bb0090","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/biom12070878","article-title":"Target-Based small molecule drug discovery for colorectal cancer: A Review of Molecular Pathways and In Silico Studies","volume":"7","author":"Moshawih","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2026.110505_bb0095","doi-asserted-by":"crossref","first-page":"27244","DOI":"10.1039\/D3RA03867J","article-title":"Enhancing solubility and stability of sorafenib through cyclodextrin-based inclusion complexation: in silico and in vitro studies","volume":"13","author":"Amana","year":"2023","journal-title":"RSC Adv."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110505_bb0100","article-title":"Hydroxychalcones as Potential Anti-Angiogenic Agent","volume":"33","author":"Karki","year":"2012","journal-title":"Bull. Korea"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110505_bb0105","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1248\/bpb.29.1028","article-title":"Anti-angiogenic and anti-tumor activities of 20-hydroxy-40- methoxychalcone","volume":"29","author":"Lee","year":"2006","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110505_bb0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/14756366.2020.1861606","article-title":"Novel piperazine\u2013chalcone hybrids and related pyrazoline analogues targeting vegfr-2 kinase; design, synthesis, molecular docking studies, and anticancer evaluation","volume":"36","author":"Ahmed","year":"2021","journal-title":"J. Enzyme Inhib. Med Chem."},{"key":"10.1016\/j.bioorg.2026.110505_bb0115","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/biom11060894","article-title":"Chalcone derivatives: Role in anticancer therapy","volume":"11","author":"Ouyang","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2026.110505_bb0120","doi-asserted-by":"crossref","first-page":"11029","DOI":"10.1016\/j.cbi.2022.110297","article-title":"Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer","volume":"369","author":"WalyEldeen","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2026.110505_bb0125","doi-asserted-by":"crossref","unstructured":"L Varinska, M van Wijhe, M. Belleri, S. Mitola, P Perjesi, M Presta, P Koolwijk, L Ivanova, J Mojzis, Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. Eur. J. Pharmacol.; 691(1-3): (2012) 125\u2013133. http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/j.ejphar.2012.06.017.","DOI":"10.1016\/j.ejphar.2012.06.017"},{"key":"10.1016\/j.bioorg.2026.110505_bb0130","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bioorg.2018.10.071","article-title":"Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity","volume":"82","author":"Elsayed","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110505_bb0135","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1007\/s00044-023-03136-5","article-title":"Bio-evaluation of the 2-nitrochalcones as potential anti-lung cancer agents, inducers of apoptosis and inhibitors of protein kinase (VEGFR-2)","volume":"32","author":"Mphahlele","year":"2023","journal-title":"Med. Chem. Res."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110505_bb0140","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/cmdc.202000658","article-title":"Recent Advances in the Discovery of Multitargeted Tyrosine Kinase Inhibitors as Anticancer Agents","volume":"16","author":"Guo","year":"2021","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110505_bb0145","doi-asserted-by":"crossref","first-page":"31908","DOI":"10.1039\/D3RA05066A","article-title":"Novel quinoxaline-3-propanamides as VGFR-2 inhibitors and apoptosis inducers","volume":"13","author":"Ismail","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110505_bb0150","first-page":"139","article-title":"Novel Quinoxaline-based VEGFR-2 Inhibitors to Halt Angiogenesis","author":"Ismail","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110505_bb0155","doi-asserted-by":"crossref","first-page":"11565","DOI":"10.1039\/D3NJ01638B","article-title":"Mimicry of sorafenib: novel diarylureas as VEGFR2 inhibitors and apoptosis inducers in breast cancer","volume":"47","author":"Ismail","year":"2023","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2026.110505_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106036","volume":"127","author":"Patel","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110505_bb0165","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00044-024-03188-1","article-title":"Novel biologically active pyridine derivatives: Synthesis, structure characterization, in vitro antimicrobial evaluation and structureactivity relationship","volume":"33","author":"Elsayed","year":"2024","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.110505_bb0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jscs.2010.10.017","article-title":"Study of Michael addition on chalcones and or chalcone analogues","volume":"16","author":"Aljaber","year":"2012","journal-title":"J Saud Chem Soc"},{"key":"10.1016\/j.bioorg.2026.110505_bb0175","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1752-153X-8-32","article-title":"Synthesis, characterization and evaluation of antioxidant activities of some novel chalcones analogues","volume":"8","author":"Lahsasni","year":"2014","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.bioorg.2026.110505_bb0180","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1158\/0008-5472.CAN-23-3031","article-title":"HTS384 NCI60: The Next Phase of the NCI60 Screen","volume":"84","author":"Kunkel","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110505_bb0185","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-61779-080-5_20","article-title":"Cell sensitivity assays: The MTT assay","volume":"731","author":"van Meerloo","year":"2011","journal-title":"Methods Mol. Biol."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110505_bb0195","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamaoncol.2016.0256","article-title":"Molecular Subtypes of KIT\/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic","volume":"2","author":"Boikos","year":"2016","journal-title":"JAMA oncology"},{"key":"10.1016\/j.bioorg.2026.110505_bb0200","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.canlet.2019.05.025","article-title":"AKT and ERK dual inhibitors: The way forward?","volume":"459","author":"Cao","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2026.110505_bb0205","series-title":"ERK1\/2 [pThr202\/Tyr204] ELISA Kit, Catalog Number: EMS2ERKP","author":"Invitrogen","year":"2026"},{"key":"10.1016\/j.bioorg.2026.110505_bb0210","series-title":"Human\/Mouse\/Rat Phospho-Akt (S473) Pan Specific Catalog Number: DYC887B-2 (2 plates) DYC887B-5 (5 plates) DYC887BE (Economy)","author":"DuoSet\u00ae IC ELISA INTRACELLULAR","year":"2026"},{"key":"10.1016\/j.bioorg.2026.110505_bb0215","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1016\/j.bmc.2009.06.069","article-title":"Design, synthesis, and discovery of novel non-peptide inhibitor of Caspase-3 using ligand based and structure based virtual screening approach","volume":"17","author":"Lakshmi","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110505_bb0220","article-title":"Tumor suppressive functions of p53","volume":"5","author":"Zilfou","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110505_bb0225","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd3137","article-title":"Targeting mitochondria for cancer therapy","volume":"9","author":"Fulda","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110505_bb0230","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s13104-025-07563-y","article-title":"The increased Bax\/Bcl-2 ratio and induced apoptosis in human macrophages treated by Echinococcus granulosus hydatid cyst fluid extracellular vesicles","volume":"18","author":"Mohammad-Rahimi","year":"2025","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.bioorg.2026.110505_bb0235","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110505_bb0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110505_bb0245","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110505_bb0250","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: A webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110505_bb0255","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1080\/14756366.2022.2070744","article-title":"Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies","volume":"37","author":"Yousef","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110505_bb0260","doi-asserted-by":"crossref","first-page":"974","DOI":"10.6026\/973206300200974","article-title":"Molecular docking and simulation analysis of c-KIT and PDGFR\u03b1 with phytochemicals as dual inhibitors for GIST","volume":"20","author":"El Khattabi","year":"2024","journal-title":"Bioinformation"},{"issue":"22","key":"10.1016\/j.bioorg.2026.110505_bb0265","doi-asserted-by":"crossref","first-page":"16881","DOI":"10.1021\/acs.jafc.5c12350","article-title":"Novel insights into quinoline-based oxime ether derivatives with E\/Z isomerization possessing antifungal activity and their mechanism of action","volume":"74","author":"Yang","year":"2026","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2026.110505_bb0270","article-title":"Discovery of natural Nopol as promising antibacterial alternative with the capacity to suppress bacterial virulence and enhance plant immunity","volume":"221","author":"Di Chen","year":"2026","journal-title":"Pestic. Biochem. Physiol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110505_bb0275","doi-asserted-by":"crossref","first-page":"168","DOI":"10.21608\/aijpms.2025.331899.1297","article-title":"Anti-proliferative assessment of new chalcone\/pyridine linked urea fragment: design, synthesis and in Silico investigation","volume":"5","author":"Abdelkhalek","year":"2025","journal-title":"Azhar Int. J. Pharm. Med Sci"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:27:24Z","timestamp":1791260844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826010412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":54,"alternative-id":["S0045206826010412"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110505","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of new 1-aryl-3-phenylureas as promising PDGFRa and VEGFR-2 inhibitors and apoptosis inducers","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110505"}}